Listen
Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product PYLERA is substantial. |
Clinical Added Value
| minor |
In view of the available data and bearing in mind the current development of resistance to clarithromycin by H. pyloriin France, the Committee considers that PYLERA provides a minor improvement in actual benefit (level IV) in treatment for the eradication of Helicobacter pylori. |
English version
Contact Us
Évaluation des médicaments
